Research Article
The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas
Figure 4
Frequency charts that show association between IDH1 mutation (, (a)) and MGMT methylation status (, (b)) with IMP3 protein expression in high-grade gliomas.
(a) |
(b) |